These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3330516)

  • 1. The metabolism and fate of closantel (Flukiver) in sheep and cattle.
    Michiels M; Meuldermans W; Heykants J
    Drug Metab Rev; 1987; 18(2-3):235-51. PubMed ID: 3330516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flukicidal action of closantel against immature and mature Fasciola hepatica in experimentally infected rats and sheep.
    Maes L; Lauwers H; Deckers W; Vanparijs O
    Res Vet Sci; 1988 Mar; 44(2):229-32. PubMed ID: 3387677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a novel closantel/ivermectin injection in cattle.
    Cromie L; Ferry M; Couper A; Fields C; Taylor SM
    J Vet Pharmacol Ther; 2006 Jun; 29(3):205-11. PubMed ID: 16669865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of feed intake level on the pharmacokinetic disposition of closantel in sheep.
    Hennessy DR; Ali DN
    Int J Parasitol; 1997 Sep; 27(9):1081-6. PubMed ID: 9363491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacodynamics of the flukicidal salicylanilides, rafoxanide, closantel and oxyclosanide.
    Mohammed-Ali NA; Bogan JA
    J Vet Pharmacol Ther; 1987 Jun; 10(2):127-33. PubMed ID: 3612940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetic disposition of closantel in sheep and goats.
    Hennessy DR; Sangster NC; Steel JW; Collins GH
    J Vet Pharmacol Ther; 1993 Sep; 16(3):254-60. PubMed ID: 8230396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of closantel against experimentally induced Fascioloides magna infection in sheep.
    Stromberg BE; Schlotthauer JC; Seibert BP; Conboy GA; Newcomb KM
    Am J Vet Res; 1985 Dec; 46(12):2527-9. PubMed ID: 4083587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular plasma disposition and salivary secretion of closantel and rafoxanide in sheep.
    Swan GE; Koeleman HA; Steyn HS; Mülders MS
    J S Afr Vet Assoc; 1999 Jun; 70(2):75-9. PubMed ID: 10855826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slight resistance to the residual effect of closantel in a field strain of Haemonchus contortus which showed an increased resistance after one selection in the laboratory.
    Van Wyk JA; Gerber HM; Alves RM
    Onderstepoort J Vet Res; 1982 Dec; 49(4):257-61. PubMed ID: 6764253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.